Material is the message. This exploration of mind, media and matter, process and substance, is the theme for Wallpaper* and StoneX’s ‘Material Alchemists’ exhibition, running at the Triennale di ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech ...

The Biotechnology Master of Science degree program provides students with advanced coursework in biotechnical and biomolecular sciences. Graduates are prepared for positions in research, and ...

Forbes contributors publish independent expert analyses and insights. I write about business model strategy and execution across healthcare.

His ousting of Peter Marks—a senior official at the Food and Drug Administration and key proponent of faster drug approvals—sent biotech stocks tumbling last month and stoked concerns that the ...

One relatively small biotech company has made a breakthrough that could be used to treat a range of cancer. While it's been a poor performer for the past few years despite promising growth ...

Mark Warner, D-Va., during discussions Wednesday. “In Roanoke, I think we’re one big deal away from the incredible biotech community that is nascent here kind of breaking through to the big ...

Mural Oncology is a biotechnology company that focuses on using its protein engineering platform to develop cytokine-based immunotherapies for cancer treatment. The company aims to deliver ...

Lorenzo Paoletti, managing director, Biotech Investment Banking at Truist Securities, discussed the effects of recent job cuts and restructuring of the regulatory agencies with GEN Edge.

But, have you ever wondered: what if I could easily create my own custom wallpaper on my iPhone? This new app has the answer for you. Deco makes personal wallpaper customization accessible and ...

After San Francisco biotech company Third Harmonic Bio slashed its staff by half in February, it’s now taking a more drastic step. The inflammatory disease research company’s directors have ...

As well as identifying novel drug targets and therapeutics, the partnership will explore collaboration in R&D with leading academic and research organizations globally and support the development of ...